The transformed tumor expressing CD10, BCL2, BCL6, and MYC with high Ki-67 (~70%) is consistent with double-expressor or double-hit DLBCL, associated with rapid proliferation and transformation from FL [25]. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.